The impact of physical impairment on emotional well-being in ALS

References

• McLeod JE, Clarke DM. A review of psychosocial aspects of motor neuron disease. J Neurol Sci. 2007;258:4–10.
   PubMed Web of Science ®Google Scholar
• Brown WA, Mueller PS. Psychological function in individuals with amyotrophic lateral sclerosis (ALS). Psychosom Med. 1970;32:141–52.
   PubMed Web of Science ®Google Scholar
• Mora JS, Salas T, Fajardo ML, Iváñez L, Rodríguez- Santos F. Self-perceived emotional functioning of Spanish patients with amyotrophic lateral sclerosis: a longitudinal study. Front Psychol. 2013;3:609.
   PubMedGoogle Scholar
• Pagnini F. Psychological well-being and quality of life in amyotrophic lateral sclerosis: a review. Int J Psychol. 2013; 48:194–205.
   PubMed Web of Science ®Google Scholar
• Lulé D, Pauli S, Altintas E, Singer U, Merk T, Uttner I, et al. Emotional adjustment in amyotrophic lateral sclerosis. J Neurol. 2012;259:334–41.
   PubMed Web of Science ®Google Scholar
• Felgoise SH, Stewart JL, Bremer BA, Walsh SM, Bromberg MB, Simmons Z. The SEIQoL-DW for assessing quality of life in ALS: strengths and limitations. Amyotroph Lateral Scler. 2009;10:456–62.
   PubMed Web of Science ®Google Scholar
• Lulé D, Häcker S, Ludolph A, Birbaumer N, Kübler A. Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch Arztebl Int. 2008;105:397–403.
   PubMed Web of Science ®Google Scholar
• Simmons Z, Felgoise SH, Bremer BA, Walsh SM, Hufford DJ, Bromberg MB, et al. The ALSSQoL: balancing physical and non-physical factors in assessing quality of life in ALS. Neurology. 2006;67:1659–64.
   PubMed Web of Science ®Google Scholar
• Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000;55:388–92.
   PubMed Web of Science ®Google Scholar
• de Groot IJ, Post MW, van Heuveln T, van den Berg LH, Lindeman E. Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:356–61.
   PubMed Web of Science ®Google Scholar
• Atassi N, Cook A, Pineda CM, Yerramilli-Rao P, Pulley D, Cudkowicz M. Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:109–12.
   PubMed Web of Science ®Google Scholar
• Kübler A, Winter S, Ludolph AC, Hautzinger M, Birbaumer N. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair. 2005;19:182–93.
   PubMed Web of Science ®Google Scholar
• Albrecht GL, Devlieger PJ. The disability paradox: high quality of life against all odds. Soc Sci Med. 1999;48:977–88.
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Fitzpatrick R, Swash M, Levvy G. ALSAQ user manual: amyotrophic lateral sclerosis assessment questionnaire. Oxford: Health Services Research Unit, University of Oxford, 2001.
   Google Scholar
• Jenkinson C, Fitzpatrick R, Brennan C, Bromberg M, Swash M. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neuron disease: the ALSAQ-40. J Neurol. 1999;246 (Suppl 3):16–21.
   PubMed Web of Science ®Google Scholar
• Salas T, Mora J, Esteban J, Rodríguez F, Díaz-Lobato S, Fajardo M. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients. Amyotroph Lateral Scler. 2008;9:168–72.
   PubMed Web of Science ®Google Scholar
• Maessen M, Post MW, Maillé R, Lindeman E, Mooij R, Veldink JH, et al. Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5. Amyotroph Lateral Scler. 2007;8:96–100.
   PubMed Web of Science ®Google Scholar
• Palmieri A, Sorarù G, Lombardi L, d’Ascenzo C, Baggio L, Ermani M, et al. Quality of life and motor impairment in ALS: Italian validation of ALSAQ. Neurol Res. 2010;32:32–40.
   PubMed Web of Science ®Google Scholar
• Abdulla S, Vielhaber S, Körner S, Machts J, Heinze HJ, Dengler R, et al. Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure. J Neurol. 2013;260:2242–55.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45. London: Her Majesty's Stationary Office, 1976.
   Google Scholar
• Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847–52.
   PubMed Web of Science ®Google Scholar
• Turner MR, Wicks P, Brownstein CA, Massagli MP, Toronjo M, Talbot K, et al. Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:853–4.
   PubMed Web of Science ®Google Scholar
• Ellis CM, Simmons A, Jones DK, Bland J, Dawson JM, Horsfield MA, et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology. 1999;53:1051–8.
   PubMed Web of Science ®Google Scholar
• Wicks P, Massagli MP, Wolf C, Heywood J. Measuring function in advanced ALS validation of ALSFRS-EX extension items. Eur J Neurol. 2009;16:353–9.
   PubMed Web of Science ®Google Scholar
• Just N, Bautin N, Danel-Brunaud V, Debroucker V, Matran R, Perez T. The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis. Eur Respir J. 2010;35:353–60.
   PubMed Web of Science ®Google Scholar
• Kübler A, Winter S, Ludolph AC, Hautzinger M, Birbaumer N. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair. 2005;19:182–93.
   PubMed Web of Science ®Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995;11:707–19.
   Google Scholar
• Shoesmith CL, Findlater K, Rowe A, Strong MJ. Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry. 2007;78:629–31.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Yoshikura N, Harada N, Yamada M, Koumura A, Sakurai T, et al. Late-onset patients with sporadic amyotrophic lateral sclerosis in Japan have a higher progression rate of ALSFRS-R at the time of diagnosis. Intern Med. 2012;51:579–84.
   PubMed Web of Science ®Google Scholar
• Norquist JM, Jenkinson C, Fitzpatrick R, Swash M, ALS-HPS Steering Group. Factors which predict physical and mental health status in patients with amyotrophic lateral sclerosis over time. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:112–7.
   PubMed Web of Science ®Google Scholar
• Atassi N, Cook A, Pineda CM, Yerramilli-Rao P, Pulley D, Cudkowicz M. Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:109–12.
   PubMed Web of Science ®Google Scholar
• McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in amyotrophic lateral sclerosis. The role of psychological factors.Arch Neurol. 1994;51:17–23.
   PubMed Web of Science ®Google Scholar
• Averill AJ, Kasarskis EJ, Segerstrom SC.Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:243–54.
   PubMed Web of Science ®Google Scholar
• Ganzini L, Johnston WS, Hoffman WF.Correlates of suffering in amyotrophic lateral sclerosis. Neurology. 1999;52:1434–40.
   PubMed Web of Science ®Google Scholar
• Albert SM, Rabkin JG, Del Bene ML, et al. Wish to die in end-stage ALS. Neurology. 2005;65:68–74.
   PubMed Web of Science ®Google Scholar
• Lulé D, Nonnenmacher S, Sorg S, Heimrath J, Hautzinger M, Meyer T, et al. Live and let die: existential decision processes in a fatal disease. J Neurol. 2014; Jan 12 (Epub ahead of print).
   Google Scholar
• Hillemacher T, Grässel E, Tigges S, Bleich S, Neundörfer B, Kornhuber J, et al. Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:245–9.
   PubMed Web of Science ®Google Scholar
• Mioshi E, Caga J, Lillo P, Hsieh S, Ramsey E, Devenney E, et al. Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival. Neurology. 2014;82:149–55.
   PubMed Web of Science ®Google Scholar
• Playford D. Outcome measurement in neurological disease. Curr Opin Neurol. 2008;21:649–53.
   PubMedGoogle Scholar
• Johnston BC, Patrick DL, Busse JW, Schünemann HJ, Agarwal A, Guyatt GH. Patient-reported outcomes in meta-analyses. Part 1: assessing risk of bias and combining outcomes. Health Qual Life Outcomes. 2013;11:109.
   PubMed Web of Science ®Google Scholar
• Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(3 Suppl):S217–32.
   Google Scholar
• Westerman MJ, Hak T, The AM, Echteld MA, Groen HJ, van der Wal G. Change in what matters to palliative patients: eliciting information about adaptation with SEIQoL-DW. Palliat Med. 2007;21:581–6.
   PubMedGoogle Scholar
• Pagnini F, Simmons Z, Corbo M, Molinari E. Amyotrophic lateral sclerosis: time for research on psychological intervention? Amoytroph Lateral Scler. 2012;13:416–7.
   PubMed Web of Science ®Google Scholar
• Henschke C. Provision and financing of assistive technology devices in Germany: a bureaucratic odyssey? The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy. Health Policy. 2012;105:176–84.
   PubMed Web of Science ®Google Scholar